Sorry! This page doesn't exist anymore
Interested in attending our upcoming events? Reach out to us to get more information.

DAYBUE® Industry Supported Satellite Symposia
Managing Patients with Rett Syndrome (RTT): Spotlight on the First and Only FDA-Approved RTT-Specific Treatment
DAYBUE is indicated for the treatment of Rett Syndrome in adults and pediatric patients 2 yeas of age and older.
See DAYBUE Important Safety Information below.